P1158 Comparison of comorbidities, and lifestyle habits between IBD patients, IBD patients with suspected SpA, and controls
P Karling,N Pettersson,H Forsblad-d´Elia
DOI: https://doi.org/10.1093/ecco-jcc/jjad212.1288
2024-01-01
Journal of Crohn's and Colitis
Abstract:Abstract Background Inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), is a complex condition with systemic implications. Recent research emphasizes the connection between IBD and spondyloarthritis (SpA), sharing genetic and clinical traits. This cross-sectional case-control study investigates comorbidities and lifestyle habits in three groups: IBD patients, IBD patients with suspected SpA, and control group from the general population. Methods We obtained data from the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG) for 1,032 IBD patients (592 UC and 440 CD) and selected a control group of 16,756 individuals from the 2018 Swedish National Public Health Survey. Questionnaires covered comorbidities, self-perceived health, smoking, alcohol, and physical activity. Modified criteria for ASAS and AMOR was used to define SpA. Risk factors in patients with IBD for SpA were explored by logistic regression. Results IBD patients have higher rates of comorbidities such as hypertension (34.4%), asthma (15.6%), and diabetes (8.3%) compared to the control group.(Table 1). Notably, those with suspected concurrent SpA had even higher rates: hypertension (41.3% in axial SpA, 43.6% in peripheral SpA), asthma (22.4% in axial SpA, 21.5% in peripheral SpA), and diabetes (10.2% in axial SpA, 10.5% in peripheral SpA). Smoking habits differ, with a greater proportion of former smokers in the IBD group (38.3%) and a higher percentage of individuals who had never smoked in the control group (64.6%). Encouragingly, IBD patients demonstrated increased physical activity, with 70.3% engaging in 150 minutes of activity per week. Logistic regression analyses revealed associations between specific factors and the presence of SpA in IBD patients, including female gender (1.815, SD 1.325–2.488), BMI (1.073, SD 1.034–1.113), asthma (1.628, SD 1.038–2.553), gastritis (1.694, SD 1.070–2.683), and current/former smoking (1.359, SD1.004–1.840). Conclusion The prevalence of hypertension, asthma and diabetes were higher in patients with IBD compared to the general population. A higher proportion among the controls had never smoked but patients with IBD had lower alcohol consumption and were more physically active. This study sheds light on the IBD-SpA relationship and its impact on comorbidities and lifestyle. The findings aid clinicians in holistic patient management, emphasizing tailored care for specific comorbidities and lifestyle factors.
gastroenterology & hepatology
What problem does this paper attempt to address?